author-photo

S. Cupini

University of Pisa

50

Papers

1379

Citations

Citation Trend

Filter By

Papers (41) Sort By

Journal Conference Others

Oligometastatic colorectal cancer: prognosis, role of locoregional treatments and impact of first-line chemotherapy-a pooled analysis of TRIBE and TRIBE2 studies by Gruppo Oncologico del Nord Ovest.

2020 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (4)
Oligometastatic colorectal cancer: Prognostic implications of tumor load, role of locoregional treatments, and of first-line therapy intensification—A pooled analysis of TRIBE and TRIBE2 studies by GONO.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Upfront FOLFOXIRI Plus Bevacizumab and Reintroduction after Progression versus mFOLFOX6 Plus Bevacizumab Followed by FOLFIRI Plus Bevacizumab in the Treatment of Patients with Metastatic Colorectal Cancer (TRIBE2): A Multicentre, Open-Label, Phase 3, Randomised Controlled Trial by GONO

2019
Show All
- Source
- Cite
- Save
Citations (3)
Continuation or reintroduction of bevacizumab beyond progression to first-line therapy in metastatic colorectal cancer: final results of the randomized BEBYP trial

2015 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (104)
OUTCOME OF SECOND-LINE TREATMENT AFTER FIRST-LINE CHEMOTHERAPY WITH THE GONO FOLFOXIRI REGIMEN.

2012 Clinical Colorectal Cancer
Show All
- Source
- Cite
- Save
Citations (14)
A Randomized Phase III Study Evaluating the Continuation of Bevacizumab (BV) Beyond Progression in Metastatic Colorectal Cancer (MCRC) Patients (PTS) Who Received BV as Part of First-Line Treatment: Results of the Bebyp Trial by the Gruppo Oncologico Nord Ovest (GONO)

2012 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (22)
Cetuximab plus irinotecan after irinotecan failure in elderly metastatic colorectal cancer patients: clinical outcome according to KRAS and BRAF mutational status

2011 Critical Reviews in Oncology Hematology
Show All
- Source
- Cite
- Save
Citations (23)
Randomized Trial of Two Induction Chemotherapy Regimens in Metastatic Colorectal Cancer: An Updated Analysis

2011 Journal of the National Cancer Institute
Show All
- Source
- Cite
- Save
Citations (133)
Cetuximab plus irinotecan in irinotecan-resistant elderly metastatic coloretal cancer patients: clinical outcome according to KRAS and BRAF mutational status

2010 Critical Reviews in Oncology Hematology
Show All
- Source
- Cite
- Save
Citations (0)
Bevacizumab with FOLFOXIRI (irinotecan, oxaliplatin, fluorouracil, and folinate) as first-line treatment for metastatic colorectal cancer: a phase 2 trial

2010 Lancet Oncology
Show All
- Source
- Cite
- Save
Citations (207)